Compare NRSN & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRSN | INLX |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | Israel | United States |
| Employees | 16 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 30.4M |
| IPO Year | N/A | 2013 |
| Metric | NRSN | INLX |
|---|---|---|
| Price | $0.85 | $6.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 138.1K | 1.8K |
| Earning Date | 03-31-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,336.00 |
| Revenue This Year | N/A | $16.86 |
| Revenue Next Year | $583.67 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $6.45 |
| 52 Week High | $2.60 | $14.57 |
| Indicator | NRSN | INLX |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 36.38 |
| Support Level | $0.85 | N/A |
| Resistance Level | $1.06 | $8.52 |
| Average True Range (ATR) | 0.07 | 0.29 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 53.65 | 0.00 |
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.